2023
|
Invention
|
Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphe... |
|
Invention
|
2-methyl-quinazolines.
The present invention describes 2-methyl-quinazoline compounds of general... |
|
Invention
|
Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies.
The inve... |
|
Invention
|
Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors.
The present invention covers com... |
|
Invention
|
N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)eth... |
|
Invention
|
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh.
The present invention prov... |
|
Invention
|
Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor.
The present invention ... |
|
Invention
|
Antibody drug conjugates (adcs) having enzymatically cleavable groups.
The invention relates to ... |
|
Invention
|
Prodrugs of cytotoxic active agents having enzymatically cleavable groups.
The invention relates... |
2022
|
Invention
|
Treatment of cardiopulmonary disorders. The present invention relates to the use of (5S)-{[2-(4-c... |
|
Invention
|
Pharmaceutical dry powder inhalation formulation. The present invention relates to pharmaceutical... |
|
Invention
|
New gadolinium chelate compounds for use in magnetic resonance imaging.
An aqueous pharmaceutica... |
|
Invention
|
Substituted macrocyclic indole derivatives. The present invention relates to substituted macrocyc... |
|
Invention
|
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. The present ... |
|
Invention
|
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that conta... |
|
Invention
|
Dihydrooxadiazinones. The present invention provides dihydrooxydiazinone compounds of general for... |
|
Invention
|
Specific antibody drug conjugates (adcs) having ksp inhibitors.
Specific binder-drug conjugates ... |
|
Invention
|
Dihydrooxadiazinones.
The present invention provides dihydrooxydiazinone compounds of general fo... |
|
Invention
|
Crystalline forms of 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3r)-tetrahydrofuran-3-yloxy]-n-{(1r)-1-[2-... |
|
Invention
|
Pharmaceutical dosage forms comprising 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3r)-tetrahydrofuran-3-yl... |
|
Invention
|
Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies. The inven... |
|
Invention
|
Orally administrable modified-release pharmaceutical dosage form.
The present invention relates ... |
|
Invention
|
Combination containing sgc activators and mineralocorticoid receptor antagonists.
The present in... |
|
Invention
|
Process for preparing benzothiophen-2yl boronate.
A process for preparing the benzothiophen-2-yl... |
|
Invention
|
Macrocyclic fluorine substituted indole derivatives.
The present invention relates to macrocycli... |
|
Invention
|
Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases.
The pre... |
|
Invention
|
Novel ptefb inhibiting macrocyclic compounds.
The present invention relates to novel modified ma... |
2021
|
Invention
|
Ptefb inhibiting macrocyclic compounds. The present invention relates to novel modified macrocycl... |
|
Invention
|
Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof.
The present inven... |
|
Invention
|
Masp inhibitory compounds and uses thereof.
The present invention relates to novel Mannose-bindi... |
|
Invention
|
Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular an... |
|
Invention
|
Substituted oxopyridine derivatives.
The invention relates to substituted oxopyridine derivative... |
|
Invention
|
Carboxylic acid aromatic amides.
The present invention relates to carboxylic acid aromatic amide... |
|
Invention
|
Substituted diazahetero-bicyclic compounds and their use.
The present application relates to nov... |
|
Invention
|
Antibody drug conjugates (adcs) and antibody prodrug conjugates (apdcs) with enzymatically cleava... |
|
Invention
|
Macrocyclic indole derivatives. The present invention relates to macrocyclic indole derivatives o... |
|
Invention
|
P450 bm3 monooxygenase variants for c19-hydroxylation of steroids.
The present invention relates... |
2020
|
Invention
|
Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naph... |
|
Invention
|
Aromatic sulfonamide derivatives. Substituted aromatic sulfonamides of formula (I)
pharmaceutic... |
|
Invention
|
[1,2,4]triazolo[1,5-c]quinazolin-5-amines.
The present invention covers [1,2,4]triazolo[1,5-c]qu... |
|
Invention
|
Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}be... |
|
Invention
|
Macrocyclic chlorine substituted indole derivatives. The present invention relates to macrocyclic... |
|
Invention
|
Substituted pyrrolopyridine-derivatives. 4b are as defined herein, to pharmaceutical compositions... |
2019
|
Invention
|
Substituted dihydropyrazolo pyrazine carboxamide derivatives.
The invention relates to substitut... |
|
Invention
|
2-methyl-aza-quinazolines.
The present invention covers 2-methyl-aza-quinazoline compounds of ge... |
2018
|
Invention
|
Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-... |
2017
|
Invention
|
Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor. The present invention r... |
|
Invention
|
Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-... |
2007
|
G/S
|
Chemicals used in industry, science and photography. Soaps; perfumery, essential oils, cosmetics,... |
|
G/S
|
Pharmaceutical preparations. Surgical and medical instruments and devices, medicinal
catheters. |
2006
|
G/S
|
Chemicals used in industry, science and photography. Pharmaceutical products and health-care prod... |
1997
|
G/S
|
Pharmaceutical and sanitary preparations. |
|
G/S
|
Medicines for humans and animals. |